Rentokil Initial plc (LON:RTO - Get Free Report)'s stock price shot up 9.1% on Thursday . The company traded as high as GBX 387.30 ($5.12) and last traded at GBX 377.98 ($4.99). 13,367,716 shares traded hands during mid-day trading, an increase of 30% from the average session volume of 10,266,272 shares. The stock had previously closed at GBX 346.60 ($4.58).
Wall Street Analysts Forecast Growth
Separately, Deutsche Bank Aktiengesellschaft upped their price objective on shares of Rentokil Initial from GBX 425 ($5.61) to GBX 435 ($5.75) and gave the company a "buy" rating in a research report on Monday, July 21st.
View Our Latest Stock Report on RTO
Rentokil Initial Trading Up 9.1%
The stock has a market cap of £9.47 billion, a price-to-earnings ratio of 24.24, a price-to-earnings-growth ratio of 0.56 and a beta of 0.55. The firm's 50 day moving average is GBX 352.26 and its two-hundred day moving average is GBX 359.56. The company has a quick ratio of 1.76, a current ratio of 1.04 and a debt-to-equity ratio of 113.35.
Insiders Place Their Bets
In other Rentokil Initial news, insider Sally Johnson acquired 3,567 shares of the company's stock in a transaction that occurred on Monday, June 2nd. The shares were purchased at an average price of GBX 351 ($4.64) per share, for a total transaction of £12,520.17 ($16,539.19). 0.32% of the stock is currently owned by company insiders.
Rentokil Initial Company Profile
(
Get Free Report)
Rentokil Initial plc, together with its subsidiaries, provides route-based services in North America, the United Kingdom, rest of Europe, Asia, the Pacific, and internationally. It offers a range of pest control services for rodents, and flying and crawling insects, as well as other forms of wildlife management for commercial customers.
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Rentokil Initial, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Rentokil Initial wasn't on the list.
While Rentokil Initial currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.